SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as the community discusses potential catalysts stemming from activity surrounding the White House's social media, drawing comparisons to the stock's previous surges. Community members are debating the potential impact of this activity and its implications for a possible short squeeze. The stock's movement is also being compared to other meme stocks like BYND, with some suggesting a rotation of interest.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

CLIK is trending due to a sharp after-hours surge, fueled by a strong fiscal year revenue report showing significant year-over-year growth. The community is actively discussing its low float and potential for a substantial move, with some anticipating a short squeeze. Traders are watching for volume confirmation to validate further upside potential.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as investors anticipate upcoming earnings and potential catalysts like rate cuts and S&P 500 inclusion. The community is closely watching for a breakout above the $30 resistance level, with many expecting a significant move post-earnings. Bullish sentiment is fueled by strong growth metrics and the company's position as a disruptor in the fintech sector.

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.

Avidity Biosciences Inc

Avidity Biosciences ($RNA) is trending amid rumors of a potential acquisition by Novartis ($NVS), sending the stock soaring. The community speculates on the deal's likelihood and potential value, while noting positive clinical data and a strengthened pipeline. Discussions also involve the impact on the broader RNA therapeutics sector and comparisons to other companies in the space.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals (BCRX) is trending amid discussions around its strategic acquisition of Astria Therapeutics to bolster its hereditary angioedema (HAE) portfolio, although some investors express concern about the deal's financial implications and dilution. Community talking points include the potential of navenibart, Astria's late-stage drug, and its impact on the competitive landscape, while others question management's decision-making and the company's future growth trajectory. Analysts have weighed in with revised price targets, adding to the ongoing conversation.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle ($CRCL) is trending due to a mix of bullish sentiment and unusual options activity, specifically large volumes of out-of-the-money calls expiring in November, leading to speculation about a potential short squeeze or upcoming news. Community members are actively discussing breakout potential, key price levels, and the impact of a potential lockup expiry, with some eyeing ambitious price targets. Recent analyst ratings and broader trends in the crypto and digital asset space also appear to be fueling the conversation.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET is trending following news of a $5 million production order, signaling a move from R&D to commercialization and revenue generation, a key milestone for the company. Community members are discussing the potential for further purchase orders and partnerships, particularly highlighting the connection to Luxshare and Meta, and expecting substantial growth in the AI infrastructure market. While some express concerns about market volatility and dilution, the overall sentiment remains optimistic about POET's long-term prospects in the photonics space.

ETHZilla Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palm Beach, FL.

ETHZilla Corp

ETHZilla Corporation

ETHZilla Corporation is trending as investors discuss its potential undervaluation due to significant ETH holdings and cash reserves, with some highlighting Peter Thiel's investment as a bullish signal. Community members are actively debating its relation to the price of ETH and the possible influence of meme stock trends on its future performance, while others express concern about potential dilution from convertible notes.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals is trending due to the FDA's correction confirming VOQUEZNA's market exclusivity through 2032, driving optimism about the drug's long-term potential. The community is also discussing the upcoming earnings report and potential for a short squeeze, given the high short interest. Bullish sentiment is fueled by strong analyst ratings and the drug's superior profile compared to existing GERD treatments.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending as traders discuss the potential for a short squeeze, fueled by high borrow rates and a tightly held float. Community members are actively debating share allocation and the impact of recent insider buying, while closely monitoring short interest data. Sentiment suggests retail investors are optimistic about a potential breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Xenetic Biosciences (XBIO) Reports Q2 Loss, Misses Revenue Estimates

Xenetic Biosciences (XBIO) delivered earnings and revenue surprises of +29.69% and -7.81%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Xenetic Biosciences, Inc. Under Pressure: Shareholder Activism Threatens Stability and Financial Future

Xenetic Biosciences, Inc. (XBIO) has disclosed a new risk, in the Share Price & Shareholder Rights category. Xenetic Biosciences, Inc. faces financ...

Xenetic Biosciences reports FY results

Xenetic Biosciences reports FY results...

Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results

Continued advancement of DNase-based oncology program towards Phase 1 clinical study for the treatment of pancreatic carcinoma and other locally advanced or metastatic solid tumorsEnded the year with...

Xenetic Biosciences Inc (NASDAQ:XBIO) Short Interest Up 71.7% in January

Xenetic Biosciences Inc (NASDAQ:XBIO  Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 15th, there was short interest...

Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform

- Company building growing body of preclinical data to guide pathway to first in human trial for DNase-based oncology platformFRAMINGHAM, MA / ACCESSWIRE / January 17, 2024 / Xenetic Biosciences...

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.

Xenetic Biosciences Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

XBIO
Xenetic Biosciences Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest XBIO News

XBIOXenetic Biosciences Inc